Forsythoside A alleviates experimental autoimmune encephalomyelitis by targeting Tnfaip2
Ping Tang, Guibao Luo, Huihui Xue, Chunsheng Yang · 2026
Read Forsythoside A alleviates experimental autoimmune encephalomyelitis by targeting Tnfaip2 by Ping Tang, Guibao Luo, Huihui Xue, Chunsheng Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13418143.txt.
Description
Tang and colleagues report a 2026 study of forsythoside A, a natural compound from the plant Forsythia suspensa, tested in a mouse model of multiple sclerosis. The mouse model shares many features of that nerve-insulation disease. Mice got the compound from day seven, and the team tracked symptoms, tissue damage, immune cells, and spinal cord gene activity.
At the higher dose, mice had milder symptoms, less nerve inflammation, and less insulation loss; the lower dose helped only slightly. Treated mice also carried fewer Th1 immune cells, which drive this disease. Computer and lab work pointed to one target protein, Tnfaip2, and tests in microglia, the brain's immune cells, confirmed the link by turning that gene up and down. A plant compound with a named target gives drug developers a concrete lead against nerve inflammation.
Catalog record
| CREATOR | Ping Tang, Guibao Luo, Huihui Xue, Chunsheng Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | https://creativecommons.org/publicdomain/zero/1.0 |
| RIGHTS | CC0 |
| SOURCE | Europe PMC |